Remarkably, a recent investigation exploring the mechanism of sorafenib resistance revealed that circFN1 knockdown partly sensitized HCC cells to sorafenib by modulating miRNA-1205 and E2F1 expression [41]. This evidence concerns the gene E2F1 and hepatocellular carcinoma.